Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Telomerase Reactivation With Danazol in Ovarian Function
NCT04058678Completed
- Sponsor
- International Vaccine Institute
- Start
- Jan 2020
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of danazol in Diminished Ovarian Reserve (DOR) (2 arms), sponsored by International Vaccine Institute. Primary endpoint: Telomere length in granulosa cells. Started Jan 2020; status: completed.
02
Drugs
danazol
03
Conditions
Diminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on NCT04058678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04058678.